| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Zhen-hua Chen, Gao-hua Wang, Xiao-ping Wang, Yun-xiang Huo, Ming-hua Yang, Li Li, Hong-bing Me. Effect of Warm-Supplementing Kidney Yang (WSKY) added to risperidone on quality of life in patients with schizophrenia: a randomized controlled trial. Clinical rehabilitation. vol 23. issue 11. 2010-11-15. PMID:19786416. |
to evaluate the quality of life, efficacy and safety of warm-supplementing kidney yang (wsky) added to risperidone in patients with schizophrenia. |
2010-11-15 |
2023-08-12 |
Not clear |
| Arzu Gunes, Edoardo Spina, Marja-Liisa Dahl, Maria Gabriella Scord. ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety. Therapeutic drug monitoring. vol 30. issue 5. 2010-11-08. PMID:18708991. |
forty-six white patients with schizophrenia treated with risperidone (1-10 mg/d) in monotherapy for 4-6 weeks were genotyped, and their plasma concentrations of risperidone and 9-hydroxyrisperidone were measured. |
2010-11-08 |
2023-08-12 |
Not clear |
| Keith Lloyd, Muhammud A Latif, Steve Simpson, Keshar L Shresth. Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome. Human psychopharmacology. vol 25. issue 3. 2010-11-04. PMID:20373476. |
switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome. |
2010-11-04 |
2023-08-12 |
Not clear |
| Jae Seung Chang, Cheol Sung Yoo, Sang Hoon Yi, Kye Hyun Hong, Yu-Sang Lee, Hong Seok Oh, Dong Chung Jung, Yong Sik Kim, Yong Min Ah. Changes in heart rate dynamics of patients with schizophrenia treated with risperidone. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 6. 2010-11-02. PMID:20423720. |
changes in heart rate dynamics of patients with schizophrenia treated with risperidone. |
2010-11-02 |
2023-08-12 |
human |
| Jae Seung Chang, Cheol Sung Yoo, Sang Hoon Yi, Kye Hyun Hong, Yu-Sang Lee, Hong Seok Oh, Dong Chung Jung, Yong Sik Kim, Yong Min Ah. Changes in heart rate dynamics of patients with schizophrenia treated with risperidone. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 6. 2010-11-02. PMID:20423720. |
we explored within-subject changes in hrv indices in acutely ill patients with schizophrenia treated with risperidone. |
2010-11-02 |
2023-08-12 |
human |
| Jae Seung Chang, Cheol Sung Yoo, Sang Hoon Yi, Kye Hyun Hong, Yu-Sang Lee, Hong Seok Oh, Dong Chung Jung, Yong Sik Kim, Yong Min Ah. Changes in heart rate dynamics of patients with schizophrenia treated with risperidone. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 6. 2010-11-02. PMID:20423720. |
sixteen medication-naïve or medication-free patients with dsm-iv schizophrenia completed electrocardiogram (ecg) assessments at baseline and after six weeks of treatment with risperidone. |
2010-11-02 |
2023-08-12 |
human |
| Jae Seung Chang, Cheol Sung Yoo, Sang Hoon Yi, Kye Hyun Hong, Yu-Sang Lee, Hong Seok Oh, Dong Chung Jung, Yong Sik Kim, Yong Min Ah. Changes in heart rate dynamics of patients with schizophrenia treated with risperidone. Progress in neuro-psychopharmacology & biological psychiatry. vol 34. issue 6. 2010-11-02. PMID:20423720. |
these results indicate that, in the therapeutic process, risperidone treatment may exert a beneficial influence on the sympathovagal imbalance in acute schizophrenia. |
2010-11-02 |
2023-08-12 |
human |
| M Lambert, T De Marinis, J Pfeil, D Naber, A Schreine. Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment. European psychiatry : the journal of the Association of European Psychiatrists. vol 25. issue 4. 2010-10-28. PMID:19926263. |
establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment. |
2010-10-28 |
2023-08-12 |
Not clear |
| Georges Brousse, Alexandre Meary, Olivier Blanc, Christophe Lançon, Pierre Michel Llorca, Marion Leboye. Clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia. Psychiatry research. vol 179. issue 1. 2010-10-12. PMID:20472305. |
clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia. |
2010-10-12 |
2023-08-12 |
Not clear |
| Marija Vucić Peitl, Eudard Pavlović, Antun Peitl, Vjekoslav Peit. Amenorrhoea - consequence of combined treatment with sulpiride and risperidone in a patient suffering from schizophrenia. Psychiatria Danubina. vol 22. issue 1. 2010-10-08. PMID:20305607. |
amenorrhoea - consequence of combined treatment with sulpiride and risperidone in a patient suffering from schizophrenia. |
2010-10-08 |
2023-08-12 |
Not clear |
| Claudine M Chwieduk, Gillian M Keatin. Paliperidone extended release: a review of its use in the management of schizophrenia. Drugs. vol 70. issue 10. 2010-10-04. PMID:20568835. |
paliperidone, the major active metabolite of the atypical antipsychotic risperidone, is available in an oral extended-release (er) formulation (invega(r)) and is indicated for the acute and maintenance treatment of schizophrenia in adults in the us and the eu. |
2010-10-04 |
2023-08-12 |
Not clear |
| R M Abou El-Magd, H K Park, T Kawazoe, S Iwana, K Ono, S P Chung, M Miyano, K Yorita, T Sakai, K Fuku. The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia. Journal of psychopharmacology (Oxford, England). vol 24. issue 7. 2010-09-16. PMID:19329549. |
the effect of risperidone on d-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia. |
2010-09-16 |
2023-08-12 |
mouse |
| J Du, A Zhang, L Wang, J Xuan, L Yu, R Che, X Li, N Gu, Z Lin, G Feng, Q Xing, L H. Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients. Journal of psychopharmacology (Oxford, England). vol 24. issue 7. 2010-09-16. PMID:19395426. |
relationship between response to risperidone, plasma concentrations of risperidone and cyp3a4 polymorphisms in schizophrenia patients. |
2010-09-16 |
2023-08-12 |
Not clear |
| J Du, A Zhang, L Wang, J Xuan, L Yu, R Che, X Li, N Gu, Z Lin, G Feng, Q Xing, L H. Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients. Journal of psychopharmacology (Oxford, England). vol 24. issue 7. 2010-09-16. PMID:19395426. |
all 130 schizophrenia patients (45 men, 85 women, age 15-60 years) who met dsm-iv criteria were given risperidone for 8 weeks. |
2010-09-16 |
2023-08-12 |
Not clear |
| Joris Berwaerts, Adriaan Cleton, Stefaan Rossenu, Krishna Talluri, Bart Remmerie, Luc Janssens, Sandra Boom, Michelle Kramer, Mariëlle Eerdeken. A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia. Journal of psychopharmacology (Oxford, England). vol 24. issue 7. 2010-09-16. PMID:19825908. |
a comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia. |
2010-09-16 |
2023-08-12 |
Not clear |
| Joris Berwaerts, Adriaan Cleton, Stefaan Rossenu, Krishna Talluri, Bart Remmerie, Luc Janssens, Sandra Boom, Michelle Kramer, Mariëlle Eerdeken. A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia. Journal of psychopharmacology (Oxford, England). vol 24. issue 7. 2010-09-16. PMID:19825908. |
this double-blind, randomized, parallel-group study in patients with schizophrenia compared serum prolactin concentrations following the administration of paliperidone extended-release and risperidone immediate-release tablets. |
2010-09-16 |
2023-08-12 |
Not clear |
| Kenji Hashimot. Comments on 'The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia'. Journal of psychopharmacology (Oxford, England). vol 24. issue 7. 2010-09-16. PMID:19939869. |
comments on 'the effect of risperidone on d-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia'. |
2010-09-16 |
2023-08-12 |
Not clear |
| Se Hyun Kim, Dong Chung Jung, Yong Min Ahn, Yong Sik Ki. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series. Journal of psychopharmacology (Oxford, England). vol 24. issue 7. 2010-09-16. PMID:19942641. |
the combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series. |
2010-09-16 |
2023-08-12 |
human |
| Ranganath D Rattehalli, Mahesh B Jayaram, Michael Smit. Risperidone versus placebo for schizophrenia. Schizophrenia bulletin. vol 36. issue 3. 2010-09-16. PMID:20368309. |
risperidone versus placebo for schizophrenia. |
2010-09-16 |
2023-08-12 |
Not clear |
| J-L Goeb, S Marco, A Duhamel, G Kechid, R Bordet, P Thomas, P Delion, R Jardr. [Metabolic side effects of risperidone in early onset schizophrenia]. L'Encephale. vol 36. issue 3. 2010-09-16. PMID:20620267. |
[metabolic side effects of risperidone in early onset schizophrenia]. |
2010-09-16 |
2023-08-12 |
Not clear |